# Divi's Laboratories Ltd. (Unit II), Visakhapatnam District, India – FDA Inspections

Source: https://www.keypedia.com/companies/divis-laboratories-ltd-unit-ii/b2498cb9-d277-498a-b32b-037e04f6feaf

> Inspection records and compliance data for Divi's Laboratories Ltd. (Unit II) in Visakhapatnam District. 9 FDA inspections on record (1 OAI), 2 Form 483s, last inspected July 19, 2024.

---

## Details

- Name: Divi's Laboratories Ltd. (Unit II)
- FEI Number: 3004149463
- Facility Type: API manufacturer
- Business Operations: API MANUFACTURE
- Address Line 1: Chippada Village, Annavaram, Bheemunipatnam Mandal
- City: Visakhapatnam District
- Country Name: India
- Address: Chippada Village, Annavaram, Bheemunipatnam Mandal, Visakhapatnam District, India
- Country: India

## Related Documents

- [483 - Divi's Laboratories Ltd. (Unit II) - 2024-07-19](https://www.keypedia.com/records/483/divis-laboratories-ltd-unit-ii/c752310d-e2c0-48fa-af91-1e0c7248a11c) — source: FDA, date: July 19, 2024
- FDA Inspection 1244994 - Divi's Laboratories Ltd. (Unit II) - 2024-07-19 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 19, 2024
- FDA Inspection 1121124 - Divi's Laboratories Ltd. (Unit II) - 2020-01-31 — classification: No Action Indicated (NAI), source: FDA, date: January 31, 2020
- FDA Inspection 1098033 - Divi's Laboratories Ltd. (Unit II) - 2019-06-15 — source: FDA, date: June 15, 2019
- [483 - Divi's Laboratories Ltd. (Unit II) - 2017-09-19](https://www.keypedia.com/records/483/divis-laboratories-ltd-unit-ii/85a9b4a5-0956-4d81-8d9f-f4a55c288d6b) — source: FDA, date: September 19, 2017
- [FDA Inspection 1029997 - Divi's Laboratories Ltd. (Unit II) - 2017-09-19](https://www.keypedia.com/records/fda_inspections/divis-laboratories-ltd-unit-ii/8de2af83-6a2e-41db-85f2-4ba57b235649) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 19, 2017
- [483 - Divi's Laboratories Ltd. (Unit II) - 2016-12-06](https://www.keypedia.com/records/483/divis-laboratories-ltd-unit-ii/23cae6f9-b800-4f8d-8dd8-6ba18bdd4665) — source: FDA, date: December 6, 2016
- [FDA Inspection 996506 - Divi's Laboratories Ltd. (Unit II) - 2016-12-06](https://www.keypedia.com/records/fda_inspections/divis-laboratories-ltd-unit-ii/527a19bd-80f8-4b24-ab51-0d4ab07cf2d1) — classification: Official Action Indicated (OAI), source: FDA, date: December 6, 2016
- FDA Inspection 960638 - Divi's Laboratories Ltd. (Unit II) - 2016-02-19 — classification: No Action Indicated (NAI), source: FDA, date: February 19, 2016
- FDA Inspection 888915 - Divi's Laboratories Ltd. (Unit II) - 2014-06-06 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 6, 2014
- FDA Inspection 793556 - Divi's Laboratories Ltd. (Unit II) - 2012-07-19 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 19, 2012
- FDA Inspection 577781 - Divi's Laboratories Ltd. (Unit II) - 2009-04-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 9, 2009

## Related Companies

- [NEULAND LABORATORIES LIMITED](https://www.keypedia.com/companies/neuland-laboratories-limited/8d66caaa-b135-426e-b56e-1e1d00ee62a0)
- [Melody Healthcare Private Ltd](https://www.keypedia.com/companies/melody-healthcare-private-ltd/74b97597-cbeb-48c5-b01c-1f15d7588676)
- [Neuland Laboratories Limited (Unit II)](https://www.keypedia.com/companies/neuland-laboratories-limited-unit-ii/59503c03-6ca1-4d3b-b4fe-ddbe511d8126)
- [Biocon Limited](https://www.keypedia.com/companies/biocon-limited/07b7e0b0-62d0-4d0c-8a2a-98090936a85a)
- [Auro Peptides Limited](https://www.keypedia.com/companies/auro-peptides-limited/4b0dd862-e510-4737-9a98-522e70a98627)
- [Centaur Pharmaceuticals Private Ltd.](https://www.keypedia.com/companies/centaur-pharmaceuticals-private-ltd/f96f4f92-5b20-4b5d-91d8-5b0dbe430494)
- [Laurus Labs Limited](https://www.keypedia.com/companies/laurus-labs-limited/5b25ff33-3634-4c5a-ad0c-2a1dba0c1efb)
- [Sun Pharmaceutical Industries Ltd](https://www.keypedia.com/companies/sun-pharmaceutical-industries-ltd/771469b2-c59c-423e-9ae7-6ce113d3928a)
- [Novacyl (Thailand) Ltd.](https://www.keypedia.com/companies/novacyl-thailand-ltd/a3ab6219-74d7-42bc-a5b7-c5ad487f81dd)
- [Meiji Seika Pharma Co., Ltd. - Gifu Plant](https://www.keypedia.com/companies/meiji-seika-pharma-co-ltd-gifu-plant/a0899cb0-5341-4138-a818-189061dae9ad)

## Related Officers

- [Consumer Safety Officer at Commissioned Corps of the U.S. Public Health Service](https://www.keypedia.com/people/latorie-s-jones/086d0897-7d63-4fa8-bdce-f1d17885abd7)
- [Biologist at CBER](https://www.keypedia.com/people/massoud-motamed/a8b363de-eb95-4bd3-8c05-9c34bbdbdc8a)
- [Compliance Officer / Investigator](https://www.keypedia.com/people/erika-v-butler/3e654530-4c29-403d-880e-a5422315c3c0)
- [Regulatory Affairs Specialist](https://www.keypedia.com/people/andrew-le/573464c0-de29-4f64-ab33-62543b7fe719)
- [issuing_officer](https://www.keypedia.com/people/khoa-nathan-v-tran/678e5634-237c-4395-88a1-7418479e83c7)
